List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 36 studies with search of: "Bendamustine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Dasatinib;   Drug: Combination of Bendamustine + Dasatinib;   Drug: Dasatinib;   Drug: Combination of Bendamustine + Dasatinib
2 Recruiting Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies
Conditions: Leukemia;   Lymphoma
Interventions: Drug: Bendamustine;   Drug: Rituximab;   Drug: Fludarabine;   Procedure: Stem Cell Transplant (SCT)
3 Recruiting Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Conditions: Chronic Lymphocytic Leukemia;   Non-Hodgkin's Lymphoma
Interventions: Drug: bendamustine and lenalidomide;   Drug: BL-NHL;   Drug: BLR-CLL;   Drug: BLR-NHL
4 Recruiting Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Bendamustine;   Drug: Rituximab
5 Recruiting Bendamustine in Acute Leukemia and MDS
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia
Intervention: Drug: Bendamustine
6 Recruiting Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors
Condition: Brain Metastases
Intervention: Drug: Bendamustine
7 Recruiting Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: bortezomib;   Drug: bendamustine;   Drug: rituximab
8 Active, not recruiting A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: Bendamustine
9 Recruiting Open Trial of Bendamustine HCL in Women With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Bendamustine HCL
10 Recruiting Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma
Conditions: Hodgkin's Disease;   Lymphoma
Intervention: Drug: bendamustine hcl
11 Recruiting Study to Investigate the Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy
Condition: Malignancy
Intervention: Drug: bendamustine
12 Recruiting Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Condition: Diffuse Large B-Cell Lymphoma
Interventions: Drug: bendamustine;   Drug: rituximab
13 Recruiting Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
14 Active, not recruiting SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: bendamustine and rituximab
15 Recruiting A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma
Condition: Follicular Lymphoma
Intervention: Drug: VELCADE, bendamustine and rituximab
16 Active, not recruiting Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Bendamustine HCl
17 Not yet recruiting Study of Bendamustine Hydrochloride in Combination With Rituximab in the Treatment of Patients With Relapsed/Refractory Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Intervention: Drug: Bendamustine in combination with Rituximab
18 Recruiting Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer;   Chemonaive;   Extensive Stage
Intervention: Drug: Bendamustine, Irinotecan, Etoposide/Carboplatin
19 Recruiting Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)
Conditions: Non-Hodgkin's Lymphoma;   Mantle Cell Lymphoma
Interventions: Drug: bendamustine and rituximab;   Drug: R-CVP or R-CHOP
20 Completed Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: SDX-105

Previous Page Studies Shown (1-20) Next Page (21-36)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services